With respect to the evident lack of full treatment for the Fee-Per-Use plan sales, I think this is relevant:
The company has a new CFO, officially starting Jan 1 -- on board, Dec 10. While I have no specific scenario to suggest, I think it likely there will be some announcements that clarify why a substantial amount of revenue from claimed sales has not yet been reported in the SEC filings.
http://finance.yahoo.com/news/bsd-medical-appoints-william-barth-173000372.html
Clip:
"BSD Medical Corporation ( BSDM) (Company or BSD) ( www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced the appointment of William S. (Bill) Barth as Chief Financial Officer and Corporate Secretary. Mr. Barth commenced his employment with the Company on December 10, 2012, and will assume the duties of Chief Financial Officer and Corporate Secretary effective January 1, 2013, upon the departure of Dennis Gauger, current Chief Financial Officer and Corporate Secretary. "
For rumor hawks, Mr. Barth has experience with "several equity, debt and merger transactions". However, I am not suggesting a buy-out or merger is the impetus for a new CFO. The company has mentioned they have provisions to prevent a hostile takeover, and I see no advantage to them in a buy-out or merger. An alliance with a larger company is, however, likely -- and the company has been mentioning that such is being actively sought. I believe the BSD-2000/3D/MRI is a likely basis for such an alliance, as GE and Seimens are the major mfrs of MRI machines -- so, a natural basis for an allliance -- and BSD Medical has been working with both of these MRI companies re the BSD-2000/3D/MRI product. This is a VERY powerful combination, and it is proving out well. |
